UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.
UC San Diego among sites across the country seeking to recruit up to 30,000 participants, with hopes of developing and confirming an effective vaccine to prevent COVID-19 by end of year
During the COVID-19 pandemic, Moores Cancer Center at UC San Diego Health continues to offer potentially lifesaving treatment through cancer clinical trials.
Researchers at UC San Diego Health have joined a national research study called Hyperbaric Oxygen Brain Injury Treatment (HOBIT) to assess whether therapy involving 100 percent oxygen under pressure might also benefit patients with severe brain injuries.
Every 15 seconds someone in the United States suffers a traumatic brain injury; a new research study at UC San Diego Health seeks to improve treatment options
UCI Anti-Cancer Challenge, a movement to raise awareness and funds for cancer research, is going virtual for 2020 in order to maintain social distancing and safeguard participant health. The reimagined Anti-Cancer Challenge now includes an eight-week virtual fundraising and wellness program that connects people around the local community and across…
A New England Journal of Medicine editorial by UCI Health physicians highlights the need for clinicians to fully present opportunities and ethical choices to patients who face end-stage renal failure. The editorial, “Ensuring choice for people with kidney failure — dialysis, supportive care, and hope,” by Kamyar Kalantar-Zadeh, MD, MPH…
